AIMS/HYPOTHESIS: A normal consequence of increased energy intake and insulin resistance is compensatory hyperinsulinaemia through increased insulin secretion and/or reduced insulin clearance. Failure of compensatory mechanisms plays a central role in the pathogenesis of type 2 diabetes mellitus; consequently, it is critical to identify in vivo signal(s) involved in hyperinsulinaemic compensation. We have previously reported that high-fat feeding leads to an increase in nocturnal NEFA concentration. We therefore designed this study to test the hypothesis that elevated nocturnal NEFA are an early signal for hyperinsulinaemic compensation for insulin resistance. METHODS: Blood sampling was conducted in male dogs to determine 24 h profiles of NEFA at baseline and during high-fat feeding with and without acute nocturnal NEFA suppression using a partial A1 adenosine receptor agonist. RESULTS: High-fat feeding increased nocturnal NEFA and reduced insulin sensitivity, effects countered by an increase in acute insulin response to glucose (AIR(g)). Pharmacological NEFA inhibition after 8 weeks of high-fat feeding lowered NEFA to baseline levels and reduced AIR(g) with no effect on insulin sensitivity. A significant relationship emerged between nocturnal NEFA levels and AIR(g). This relationship indicates that the hyperinsulinaemic compensation induced in response to high-fat feeding was prevented when the nocturnal NEFA pattern was returned to baseline. CONCLUSIONS/ INTERPRETATION: Elevated nocturnal NEFA are an important signal for hyperinsulinaemic compensation during diet-induced insulin resistance.
AIMS/HYPOTHESIS: A normal consequence of increased energy intake and insulin resistance is compensatory hyperinsulinaemia through increased insulin secretion and/or reduced insulin clearance. Failure of compensatory mechanisms plays a central role in the pathogenesis of type 2 diabetes mellitus; consequently, it is critical to identify in vivo signal(s) involved in hyperinsulinaemic compensation. We have previously reported that high-fat feeding leads to an increase in nocturnal NEFA concentration. We therefore designed this study to test the hypothesis that elevated nocturnal NEFA are an early signal for hyperinsulinaemic compensation for insulin resistance. METHODS: Blood sampling was conducted in male dogs to determine 24 h profiles of NEFA at baseline and during high-fat feeding with and without acute nocturnal NEFA suppression using a partial A1 adenosine receptor agonist. RESULTS: High-fat feeding increased nocturnal NEFA and reduced insulin sensitivity, effects countered by an increase in acute insulin response to glucose (AIR(g)). Pharmacological NEFA inhibition after 8 weeks of high-fat feeding lowered NEFA to baseline levels and reduced AIR(g) with no effect on insulin sensitivity. A significant relationship emerged between nocturnal NEFA levels and AIR(g). This relationship indicates that the hyperinsulinaemic compensation induced in response to high-fat feeding was prevented when the nocturnal NEFA pattern was returned to baseline. CONCLUSIONS/ INTERPRETATION: Elevated nocturnal NEFA are an important signal for hyperinsulinaemic compensation during diet-induced insulin resistance.
Authors: Stella P Kim; Karyn J Catalano; Isabel R Hsu; Jenny D Chiu; Joyce M Richey; Richard N Bergman Journal: Am J Physiol Endocrinol Metab Date: 2007-01-30 Impact factor: 4.310
Authors: Jane Shearer; David L Severson; Lin Su; Luiz Belardinelli; Arvinder K Dhalla Journal: J Pharmacol Exp Ther Date: 2008-10-24 Impact factor: 4.030
Authors: Sara Rigazio; Hanna-Riikka Lehto; Helena Tuunanen; Kjell Någren; Mikko Kankaanpaa; Claudia Simi; Ronald Borra; Alexandru G Naum; Riitta Parkkola; Juhani Knuuti; Pirjo Nuutila; Patricia Iozzo Journal: Am J Physiol Endocrinol Metab Date: 2008-05-27 Impact factor: 4.310
Authors: Thierry Alquier; Marie-Line Peyot; Martin G Latour; Melkam Kebede; Christina M Sorensen; Stephane Gesta; C Ronald Kahn; Richard D Smith; Thomas L Jetton; Thomas O Metz; Marc Prentki; Vincent Poitout Journal: Diabetes Date: 2009-08-31 Impact factor: 9.461
Authors: Kelly M Ness; Stephen M Strayer; Nicole G Nahmod; Anne-Marie Chang; Orfeu M Buxton; Gregory C Shearer Journal: Am J Physiol Regul Integr Comp Physiol Date: 2019-03-20 Impact factor: 3.619
Authors: Lucia Russo; Harrison T Muturi; Hilda E Ghadieh; Simona S Ghanem; Thomas A Bowman; Hye Lim Noh; Sezin Dagdeviren; Godwin Y Dogbey; Jason K Kim; Garrett Heinrich; Sonia M Najjar Journal: Diabetologia Date: 2017-09-14 Impact factor: 10.122
Authors: Gregory J Morton; Kenjiro Muta; Karl J Kaiyala; Jennifer M Rojas; Jarrad M Scarlett; Miles E Matsen; Jarrell T Nelson; Nikhil K Acharya; Francesca Piccinini; Darko Stefanovski; Richard N Bergman; Gerald J Taborsky; Steven E Kahn; Michael W Schwartz Journal: Diabetes Date: 2017-01-23 Impact factor: 9.461
Authors: Jacob D Kohlenberg; Marcello C Laurenti; Aoife M Egan; Daniel Schembri Wismayer; Kent R Bailey; Claudio Cobelli; Chiara Dalla Man; Adrian Vella Journal: Diabetologia Date: 2022-09-16 Impact factor: 10.460
Authors: Johan Staaf; Sarojini J K A Ubhayasekera; Ernest Sargsyan; Azazul Chowdhury; Hjalti Kristinsson; Hannes Manell; Jonas Bergquist; Anders Forslund; Peter Bergsten Journal: Pediatr Res Date: 2016-04-11 Impact factor: 3.756
Authors: Annelies Brouwer; Isaac Asare Bediako; Rebecca L Paszkiewicz; Cathryn M Kolka; Richard N Bergman; Josiane L Broussard Journal: Diabetologia Date: 2020-02-04 Impact factor: 10.122
Authors: Corey A Rynders; Rocio I Pereira; Audrey Bergouignan; Elizabeth H Kealey; Daniel H Bessesen Journal: Obesity (Silver Spring) Date: 2018-11 Impact factor: 5.002